Management of early rheumatoid arthritis

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 5, Issue 3, 2005, Pages 211-214

  Dubey, Shirish ^a   Gaffney, Karl ^a  

^a NORFOLK AND NORWICH UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Disease modifying antirheumatic drugs (DMARDS); Early arthritis; Rheumatoid arthritis; Treatment

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLD DERIVATIVE; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISOLONE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE;

DRUG SAFETY; HUMAN; MUSCLE STIFFNESS; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 21744458276     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.5-3-211     Document Type: Review

References (18)

1. Scott DL, Pugner K, Kaarela K, Doyle DV et al. The links between joint damage and disability in rheumatoid arthritis. Review. Rheumatology (Oxford) 2000;39:122-32.
2. Harrison BJ, Symmons DP. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Review. Rheumatology (Oxford) 2000; 39:939-49.
3. Hulsmans HM, Jacobs JW, van der Heijde DM, van Albada-Kuipers GA et al. The course of radiologic damage during the first six years of rheumatoid arthritis. Arthritis Rheum 2000;43:1927-40.
4. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of RA: 2002 update. Arthritis Rheum 2002;46:328-46
5. Yelin EH, Such CL, Criswell LA, Epstein WV. Outcomes for persons with rheumatoid arthritis with a rheumatologist versus a non-rheumatologist as the main physician for this condition. Med Care 1998;36: 513-22.
6. Solomon DH, Bates DW, Panush RS, Katz JN. Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Review. Ann Intern Med 1997;127:52-60.
7. Emery P, Gough A. Why early arthritis clinics? Br J Rheumatol 1991;30:241-2.
8. Emery P, Breedveld FC, Dougados M, Kalden JR et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Review. Ann Rheum Dis 2002;61:290-7.
9. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-Dose Glucocorticoid Study Group. N Engl J Med 1995;333:142-6.
10. Egsmose C, Lund B, Borg G, Pettersson H et al. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study. J Rheumatol 1995;22: 2208-13.
11. Tsakonas E, Fitzgerald AA, Fitzcharles MA, Cividino A et al. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study. J Rheumatol 2000; 27:623-9.
12. van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;124: 699-707.
13. Landewe RB, Boers M, Verhoeven AC, Westhovens R et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002; 46:347-56.
14. Andersen JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;43:22-9.
15. Kroot EJ, van Leeuwen MA, van Rijswijk MH, Prevoo ML et al. No increased mortality in patients with rheumatoid arthritis: up to 10 years of follow up from disease onset. Ann Rheum Dis 2000;59:954-8.
16. Nell VP, Machold KP, Eberl G, Stamm TA et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004;43:906-14.
17. Arnett FC, Edworthy SM, Bloch DA, McShane DJ et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
18. Scott DL. Prognostic factors in early rheumatoid arthritis. Review. Rheumatology (Oxford) 2000;39(Suppl 1): 24-9.